[…]
Arthritis News
Adalimumab Inhibits the Progression of Structural Joint Damage
[…]
Adalimumab is Safe and Efficacious as Monotherapy in Patients with Rheumatoid Arthritis
[…]
Do GPI Antibodies Serve as Biomarkers for Extraarticular Complications of RA?
[…]
Combination Therapy with Etanercept and Anakinra for Rheumatoid Arthritis
[…]
Impact of Shared Epitope Genes and Smoking on Risk of Seropositive RA Development
[…]